NCT04690972 "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
| NCT ID | NCT04690972 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Condition | Chronic Liver Disease and Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2021-01-14 |
| Primary Completion | 2021-01-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2021-01-14 with a primary completion date of 2021-01-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Development of preclinical translational models for chronic liver tumors and diseases study, such as spheroids cultured in autologous medium and murine xenograft models to test the efficacy of new therapeutic strategies.
Eligibility Criteria
Inclusion Criteria: 1. Patients * diagnosed with chronic liver disease (viral or not) * diagnosed with at least one liver nodule for which a biopsy is planned as part of the care * for hepatobiliary surgery planned as part of care * for locoregional treatment for HCC is indicated 2. Patients able to receive and understand information relating to the study and give their written informed consent 3. Patients affiliated to the French social security system Exclusion Criteria: 1. Minor patients 2. Patients under legal protection, 3. Patients subject to legal protection or unable to express their consent, 4. Patients in a situation of social fragility, 5. Pregnant or breastfeeding woman, 6. No signing of informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04690972 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Liver Disease and Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04690972 currently recruiting?
Yes, NCT04690972 is actively recruiting participants. Contact the research team at thomas.baumert@unistra.fr for enrollment information.
Where is the NCT04690972 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT04690972 clinical trial?
NCT04690972 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. The trial plans to enroll 800 participants.